The vaccine is injected intramuscularly into the deltoid muscle, newborns and young children into the upper-upper surface of the middle part of the thigh: introduction to another place reduces the effectiveness of vaccination. Before the introduction of the ampoule or syringe shake.
When vaccinating children of the first year of life and pregnant women, vaccines that do not contain preservatives are used.
A single dose for newborns and persons under 18 years of age is 0.5 ml (10 μg HBsAg). A single dose from 19 years is 1 ml (20 μg HBsAg).
A single dose for hemodialysis patients was 2 ml (40 μg HBsAg).
The vaccine in ampoules containing 1 ml of the drug (adult dose) can be used to vaccinate 2 children provided they are simultaneously vaccinated.
A vaccine in a syringe is designed to vaccinate only one patient.
Vaccination is performed within the national calendar of preventive vaccinations.
Vaccination against viral hepatitis B is administered to all newborns in the first 24 hours of the child's life.
Newborns from the risk group are vaccinated according to the scheme 0-1-2-12 (the first dose in the first 24 hours of life, the second dose at the age of 1 month, the third dose at the age of 2 months, the fourth dose at the age of 12 months. ).
Simultaneously with the first vaccination, it is recommended to inject an intramuscularly into another thigh the human immunoglobulin against hepatitis B at a dose of 100 ME. The same scheme vaccinates children at risk, not vaccinated in the maternity hospital for medical contraindications after the removal of the latter.
Children who were not vaccinated before the age of 1 and who are not at risk, as well as adolescents and adults not vaccinated before, are vaccinated according to the following scheme: 0-1-6 (1 dose - at the time of vaccination, 2 dose - after 1 month after 1 inoculation, 3 dose at 6 months from the start of immunization.)
Note: in the case of lengthening the interval between the first and second vaccinations to 5 months or more, the third inoculation is carried out 1 month after the second.
Inoculations in persons who have had contact with material infected with the hepatitis B virus are carried out according to the scheme 0-1-2 months. Simultaneously with the first vaccination, it is recommended to inject the immunoglobulin of a person against hepatitis B intramuscularly (in another place) at a dose of 100 ME (children under 10 years) or 6-8 IU / kg (other ages). Those who received a previous full course of vaccination against hepatitis B before the second vaccination determine the content of antibodies to HBsAg. If the antibody titers are at least 100 IU / L, the second and third vaccinations are not performed.
Persons at risk, due to professional duties who have constant contact with blood, should annually undergo an examination for the content of antibodies to HBsAg. In the case of a decrease in the antibody titer below 100 IU / l, a one-dose vaccine is recommended for revaccination.
Vaccinated patients who are planning surgical interventions are recommended an emergency vaccination schedule 0-7-21 days, and subsequent revaccination with a single dose of the vaccine after 12 months.
Patients of the hemodialysis department receive the vaccine four times according to the scheme 0-1-2-6 months. For injection of the drug in ampoules, only a disposable syringe is used. Place of injection before and after injection is treated with 70% alcohol. Opening of ampoules or syringes and the vaccination procedure are carried out with strict adherence to aseptic and antiseptic rules.
Do not administer intravenously.
The drug in an ampoule or syringe should be used immediately after opening the package.
Instructions for use
The device and the procedure for working with a syringe with an automatic needle protection device
A syringe device with an automatic needle protector.
Description: 1. stock; 2. clamps; 3. protective cover; 4. protective cap; 5. needle.
a - the type of syringe with the needle protection device before injection, b - the type of the syringe with the needle protection device after the injection
After completion of the injection, the needle and syringe will move back to the protective device.
Attention! Avoid contact with the clips during syringe preparation! The device is activated by pressing the rod to the terminals.
Application Rule:
1.Carefully inspect the prefilled glass syringe with a protective device.
2. Remove the protective cap from the needle.
3. Carry out the injection according to the standard procedure. Press the rod with your thumb and hold until the entire dose of the drug has been injected. The protective device is not activated until the entire dose of the drug has been injected.
4. Remove the needle, release the stem, allow the protective casing to move forward until the needle is completely protected and locked in place.
The procedure for working with a syringe with a non-automatic needle protection device
1. Injection according to standard procedure.
Attention! When carrying out the injection, it is necessary to keep the fingers on the protective cover to prevent premature activation of the protective device.
2. After the injection, move the protective device along the needle. An audible click will indicate the correctness of the action. During the entire procedure, the fingers should be behind the needle.